LIFVAYTA

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Apr 2026 filing date already counts against anyone who files later.

Record

Serial number

99770366

Mark type

Stylized text

Filed

17 Apr 2026

Published for opposition

21 Jul 2026

Attorney of record

Ronald M. Kachmarik

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical products for treating of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; chemical preparations for medical purposes, namely, for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; chemical preparations for pharmaceutical purposes, namely, for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; diagnostic preparations for medical purposes; diagnostic testing materials for medical use in the nature of diagnostic testing agents and substances for medical use

Owner

• GENFIT, Loos, FR
• GENFIT, Loos, FR

Prosecution history

• 08 Sept 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
• 08 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
• 21 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 21 Jul 2026 — PUBLISHED FOR OPPOSITION
• 15 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 23 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 22 Jun 2026 — DATA MODIFICATION COMPLETED
• 19 Jun 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 19 Jun 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 19 Jun 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 19 May 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 19 May 2026 — NON-FINAL ACTION E-MAILED
• 19 May 2026 — NON-FINAL ACTION WRITTEN
• 19 May 2026 — ASSIGNED TO EXAMINER
• 17 Apr 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED